Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.
Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of ...
The experimental SchistoShield vaccine triggered strong B-cell and T-cell immune memory in early U.S. and African clinical trials.
Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.
Adults aged 50 years and older demonstrate strong, durable immune responses after receiving an additional dose of the recombinant zoster vaccine.
Oral Rotavirus vaccines have reduced disease globally but multiple factors in low- and middle-income countries (LMICs) diminish vaccine effectiveness and disease burden remains high. A convening of ...
The continued evolution of SARS-CoV-2 variants that evade immunity highlights a need to develop vaccines that elicit variant-specific antibodies and neutralize emerging strains. However, immune ...
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
aDivision of Neurology, Department of Medicine, St Michael's Hospital, University of Toronto, Toronto, Canada bCenter for Neuroinflammation and Experimental Therapeutics and Division of multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results